9 Best Treatments for POTS in 2026

Postural orthostatic tachycardia syndrome (POTS) is a form of autonomic dysfunction where standing triggers a sustained heart rate increase of 30 or more beats per minute within 10 minutes, without a significant drop in blood pressure. Symptoms go well beyond a racing heart. Dizziness, brain fog, fatigue, exercise intolerance, and GI issues can make daily tasks feel unmanageable.

POTS diagnoses have risen more than five-fold since the COVID-19 pandemic, and the condition now affects an estimated 1 to 3 million Americans. Despite that scale, many patients wait years for a diagnosis, and treatment options remain fragmented. A 2026 international expert consensus00611-X/fulltext) now recommends multimodal, multidisciplinary management, combining behavioral, physical, and pharmacological approaches rather than relying on any single treatment.

This article ranks the nine treatments with the strongest current evidence for managing POTS symptoms in 2026.

Key Takeaways

• Brain-body behavioral programs targeting autonomic dysregulation, including CBT, ACT, and somatic tracking, are emerging as a first-line complement to standard POTS care.
• Graded recumbent exercise training increases blood volume by 6-7% and reduces orthostatic tachycardia in adults with POTS.
• Ivabradine and midodrine show the highest improvement rates among oral POTS medications in a 2025 systematic review covering 32 studies.
• Lin Health's approach is based on findings from CBT, ACT, EAET, and nervous system retraining research, delivered through trained recovery coaches with insurance coverage.
• Talk with a cardiologist or neurologist before changing your POTS management plan, as these treatments work within a coordinated care strategy.

1. Brain-Body Behavioral Therapy Programs

POTS is increasingly understood as a condition involving centralized autonomic dysregulation, not just a cardiovascular problem. The same mechanisms that keep a pain alarm "stuck" in the nervous system may also keep the autonomic threat response locked in overdrive. Behavioral therapy programs that target these central processes offer a way to address the root dysregulation rather than managing individual symptoms in isolation.

How They Target POTS

Behavioral approaches for POTS work by modulating the brain's threat-detection system. When the nervous system interprets standing as dangerous, it floods the body with adrenaline and raises heart rate beyond what the situation requires. Programs using cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), emotional awareness and expression therapy (EAET), and somatic tracking help patients reduce this heightened threat response by retraining how the brain processes autonomic signals.

A 2026 conceptual analysis found that 30.5% of POTS patients scored high on ACEs, with these scores correlating positively with symptom severity. Patients with co-occurring PTSD reported higher symptom scores compared to those without (87.16 vs 64.41 on the MALMO POTS Inventory). This supports the premise that autonomic dysregulation in POTS has a significant brain-mediated component.

What the Research Shows

Researchers recently adapted Pain Reprocessing Therapy into a POTS-specific protocol called PORT (POts Reprocessing Therapy). A 2026 pilot trial01039-9/abstract) enrolled 14 adults with POTS into an 8-session program with a pain psychologist and demonstrated feasibility and acceptability. While this is an early-phase study, it provides the first direct evidence that neuroplasticity-based behavioral interventions developed for centralized pain conditions can be adapted for autonomic dysfunction.

CBT has also been studied in familial dysautonomia trials, where 8-week programs helped patients manage the anxiety, avoidance, and negative thought patterns that compound autonomic symptoms. Separately, CBT improved autonomic markers including heart rate variability in adults with fibromyalgia, a condition that shares autonomic dysregulation features with POTS.

Who It May Help

Adults with POTS whose symptoms are amplified by anxiety, hypervigilance, fear of standing, or a history of trauma. Also a strong fit for patients who have tried medications without adequate relief and are looking for a complementary approach that addresses nervous system regulation directly. Programs like Lin Health offer coach-led behavioral therapy combining CBT, ACT, EAET, and somatic tracking, delivered remotely with insurance coverage.

2. Graded Exercise Training (Levine/CHOP/Dallas Protocols)

Exercise intolerance is one of the hallmarks of POTS, yet structured exercise is also one of the treatments with the strongest evidence for lasting improvement. The key is starting in positions that minimize orthostatic stress and building up gradually over months.

How It Targets POTS

Cardiac deconditioning contributes to POTS severity in many patients. When the heart is deconditioned, it pumps less blood per beat (lower stroke volume), so the body compensates by increasing heart rate. Graded exercise training reverses this by increasing blood volume by 6-7%, building left ventricular mass, and improving stroke volume so the heart doesn't need to race to maintain blood pressure.

What the Research Shows

The Levine Protocol (also called the Dallas Protocol) established the foundational evidence. A 3-month recumbent exercise program increased blood volume and reduced orthostatic tachycardia in POTS patients, with continued improvement through six months. The program starts with recumbent-only cardio (rowing, recumbent cycling, swimming) and adds upright exercise only after months of adaptation.

A 2023 randomized trial found that semi-supervised training outperformed unsupervised programs for adults with POTS, suggesting that structured guidance and accountability improve outcomes. The CHOP Modified Protocol, developed at Children's Hospital of Philadelphia, follows similar principles adapted for adolescents.

Who It May Help

Nearly all adults with POTS can benefit from a graded exercise program, though the starting intensity and pace of progression need to match individual tolerance. Patients who are significantly deconditioned or have been largely sedentary due to symptom severity may see the most dramatic improvements. A recovery coach or program can provide the accountability that makes adherence realistic.

3. Ivabradine

Ivabradine is a selective heart rate-lowering medication that works by blocking the funny current (If) in the sinoatrial node. Unlike beta-blockers, it slows the heart without lowering blood pressure, making it particularly useful for POTS patients who already tend toward low blood pressure.

How It Targets POTS

POTS drives an excessive heart rate response to standing. Ivabradine directly addresses this by reducing sinus node firing rate without the vasodilatory or fatigue-inducing effects that beta-blockers can cause. For patients with the hyperadrenergic subtype of POTS (characterized by elevated norepinephrine), this targeted mechanism may be especially relevant.

What the Research Shows

A 2025 systematic review of 32 oral POTS studies found that ivabradine demonstrated a 74.51% symptomatic improvement rate, among the highest of all medications studied. A 2026 randomized crossover trial compared ivabradine, propranolol, and placebo in POTS patients and found that both active medications reduced orthostatic tachycardia below the POTS diagnostic threshold.

An earlier randomized, double-blinded, placebo-controlled crossover trial in patients with hyperadrenergic POTS found that ivabradine significantly improved heart rate and quality of life. The COVIVA study, investigating ivabradine for post-COVID POTS, reported results in 2025, adding to the evidence base.

Who It May Help

Adults with POTS whose primary complaint is excessive tachycardia, especially those who cannot tolerate beta-blockers due to low blood pressure or fatigue. Ivabradine is not yet FDA-approved specifically for POTS (it is approved for heart failure), so prescribing is off-label. Insurance coverage varies.

4. Low-Dose Beta-Blockers (Propranolol)

Beta-blockers are among the longest-studied medications for POTS and remain a first-line pharmacological option. The critical detail is dosing: low doses help, while higher doses can backfire.

How They Target POTS

Beta-blockers reduce heart rate by blocking the effects of adrenaline on beta-adrenergic receptors. In POTS, where excessive sympathetic nervous system activation drives tachycardia upon standing, this dampening effect can bring heart rate closer to a normal range during upright posture.

What the Research Shows

A landmark crossover trial found that low-dose propranolol (20 mg) significantly reduced tachycardia and improved acute symptom burden compared to placebo. Crucially, the 80 mg dose did not improve symptoms and sometimes worsened fatigue, establishing the "less is more" principle for beta-blockers in POTS.

The 2025 systematic review found that beta-blockers produced the largest heart rate reduction of any oral medication (15.7-24.3 bpm decrease) with a 64.45% symptomatic improvement rate. The 2026 crossover trial confirmed that propranolol reduced peak heart rate by approximately 25 bpm during tilt testing.

Who It May Help

Adults with POTS whose primary symptom driver is tachycardia, particularly those with resting or standing heart rates well above normal. Low-dose propranolol is widely available, inexpensive, and familiar to most prescribers. Patients with concurrent migraine may see dual benefit, as propranolol is also used for migraine prevention. Those with already-low blood pressure or significant fatigue should discuss alternatives with their physician.

5. Compression Therapy

Compression garments are one of the most accessible non-pharmacological POTS treatments and have stronger evidence than many patients realize, particularly for abdominal compression.

How It Targets POTS

When people with POTS stand, blood pools in the abdomen and legs rather than returning efficiently to the heart. Nearly one-third of blood volume can be retained in the splanchnic mesenteric bed of the abdomen. Compression garments physically counteract this pooling by increasing venous return, which improves stroke volume and reduces the compensatory heart rate spike.

What the Research Shows

A controlled study found that compression garments reduced heart rate and improved symptoms during tilt testing in a dose-dependent manner, with full abdominal and leg compression producing the greatest effect. A 2025 study confirmed that abdominal-only compression also reduced orthostatic tachycardia and improved symptoms, both acutely and after several hours of daily wear.

The research consistently shows that abdominal compression outperforms leg-only compression for POTS, because it targets the splanchnic blood pooling that thigh-high stockings miss.

Who It May Help

Nearly all adults with POTS can trial compression therapy as a low-risk complement to other treatments. Abdominal binders or high-waisted compression shorts are more effective and more practical than traditional compression stockings. Patients who experience significant symptom relief in reclined positions (suggesting blood pooling as a driver) may see the clearest benefit.

6. Salt and Fluid Optimization

Increasing salt and fluid intake is the simplest and most universally recommended first-line intervention for POTS. The goal is to expand blood volume so there is more fluid available to circulate when standing.

How It Targets POTS

Higher sodium intake increases extracellular fluid and plasma volume, at least in the short-to-medium term. With more circulating volume, the heart doesn't need to compensate as aggressively when blood shifts downward upon standing. This directly addresses the low blood volume that contributes to orthostatic intolerance in many POTS patients.

What the Research Shows

A review in Autonomic Neuroscience confirmed that salt supplementation increases plasma volume and improves orthostatic tolerance in patients with POTS and vasovagal syncope. Short-term supplementation (~3 months) led to longer standing tolerance during testing, smaller heart rate increases, and enhanced peripheral vascular responses. Current guidelines from the Heart Rhythm Society consensus recommend 10-12 grams of salt and 2-3 liters of fluid daily.

It is worth noting that evidence for the long-term persistence of blood volume expansion from dietary salt is limited. The CAlgary SAlt for POTS trial (NCT05924646) is currently investigating this question.

Who It May Help

Nearly all adults with POTS who do not have cardiovascular or renal conditions that preclude high salt intake. Salt and fluid loading is inexpensive, immediately accessible, and can begin before a formal diagnosis. Patients who notice symptom improvement with IV saline infusions are particularly likely to benefit from daily oral volume expansion.

7. Midodrine

Midodrine is an alpha-1 agonist that constricts blood vessels, raising blood pressure and counteracting the venous pooling that triggers POTS symptoms. It targets a different mechanism than heart rate-lowering medications and is often used in combination with beta-blockers or ivabradine.

How It Targets POTS

Instead of slowing the heart, midodrine tightens peripheral blood vessels so less blood pools in the lower body upon standing. This improves venous return to the heart and reduces the compensatory tachycardia that defines POTS.

What the Research Shows

The 2025 systematic review found that midodrine demonstrated a 77.76% improvement rate with a 10.3 bpm standing heart rate reduction. One comparative study found that midodrine suppressed standing heart rate to 92.8 bpm in POTS patients. However, standing time did not significantly improve with midodrine alone and was more effective when combined with other treatments.

A 2025 randomized trials review identified midodrine as one of the reasonable front-line pharmacological options, alongside ivabradine and beta-blockers.

Who It May Help

Adults with POTS who have significant blood pressure drops or blood pooling as a primary symptom driver. Midodrine can be combined with a beta-blocker (one for heart rate, one for blood pressure) for patients who need both mechanisms addressed. It is typically taken 2-3 times daily and should not be taken within 4 hours of bedtime due to supine hypertension risk.

8. Heart Rate Variability Biofeedback

Heart rate variability (HRV) biofeedback teaches patients to influence their autonomic nervous system through guided breathing exercises, using real-time physiological monitoring. For POTS, where sympathetic dominance and low vagal tone drive symptoms, HRV biofeedback offers a way to strengthen parasympathetic activity.

How It Targets POTS

HRV biofeedback uses paced breathing at an individual's resonance frequency (typically 5-6 breaths per minute) combined with real-time monitoring to strengthen baroreflex sensitivity and improve autonomic balance. In POTS, where the sympathetic system tends to dominate, training the vagus nerve through repeated slow-breathing sessions may help shift the balance toward parasympathetic regulation.

What the Research Shows

A feasibility study tested HRV biofeedback via slow diaphragmatic breathing in individuals with Long COVID dysautonomia, using 10-minute sessions twice daily for 4 weeks with an ECG chest strap and phone application. A 2026 dysautonomia review presented evidence that HRV biofeedback reduces systemic inflammation, enhances emotional regulation, and improves autonomic tone.

POTS-specific randomized controlled trials of HRV biofeedback have not yet been published. The evidence is currently extrapolated from related dysautonomia populations and general HRV biofeedback research.

Who It May Help

Adults with POTS who are motivated to practice daily breathing exercises and have access to an HRV monitoring device (chest strap or wearable). HRV biofeedback is low-risk and can complement any other POTS treatment. It may particularly suit patients who notice that stress, anxiety, or shallow breathing patterns worsen their symptoms. Many brain-body behavioral programs incorporate similar breathing and autonomic regulation techniques.

9. Vagus Nerve Stimulation (Emerging)

Non-invasive transcutaneous vagus nerve stimulation (tVNS) is a newer approach that directly stimulates the vagus nerve through the ear or neck, aiming to boost parasympathetic activity and calm the overactive sympathetic response in POTS.

How It Targets POTS

tVNS delivers mild electrical pulses to the auricular branch of the vagus nerve, which projects to brainstem autonomic centers. This may reduce antiautonomic autoantibodies and inflammatory cytokines while improving overall autonomic tone, addressing the underlying autonomic imbalance rather than a single symptom.

What the Research Shows

A 2024 sham-controlled trial found that two months of active tVNS reduced orthostatic heart rate increase compared to sham stimulation in POTS patients. A 2025 systematic review graded the evidence for symptom reduction and autonomic function improvement as moderate using the GRADE system, calling VNS a "promising treatment modality."

An ongoing trial combining auricular VNS plus breathing is expected to complete by 2028, which may clarify whether combining neuromodulation with breathing techniques enhances the effect.

Who It May Help

Adults with POTS who are interested in device-based treatment options, particularly those who have not responded adequately to medications alone. tVNS devices are commercially available (some FDA-cleared for other indications), though POTS-specific FDA clearance has not been granted. This is an emerging therapy, and patients should discuss it with a neurologist or autonomic specialist familiar with the current evidence.

How Lin Health Helps with POTS

POTS involves a nervous system that has become stuck in a heightened threat state, driving the excessive heart rate, dizziness, and fatigue that define the condition. This is the same type of centralized autonomic dysregulation that Lin Health's brain-first recovery approach was designed to address. Where traditional POTS management often focuses on individual symptoms (a medication for heart rate, salt for blood volume, compression for pooling), Lin Health targets the underlying nervous system patterns that amplify those symptoms.

Lin Health's program is based on findings from research on CBT, ACT, EAET, and somatic tracking, modalities that a 2026 pilot trial01039-9/abstract) has now begun to validate specifically for POTS through the PORT (POTS Reprocessing Therapy) adaptation. The program pairs each patient with a trained recovery coach for weekly live sessions, between-session messaging, and a structured app curriculum designed to retrain how the nervous system processes threat signals.

What makes this approach practical:

• Coach-led, not self-guided. A dedicated pain recovery coach walks patients through the program, providing accountability that self-paced apps cannot match.
• Insurance covered. Lin Health is in-network with most major insurance plans, with high coverage in Colorado, Texas, Florida, California, and New York. Most patients pay zero out of pocket.
• Short wait times. Patients typically receive a same-day callback after signing up.
• Works alongside medical care. Behavioral nervous system retraining complements medications, exercise protocols, and other POTS treatments rather than replacing them.

If you have been managing POTS symptoms with medications and lifestyle changes but still feel stuck, a behavioral approach that addresses the autonomic nervous system directly may be worth exploring. Check your eligibility now.

FAQ

What is POTS and what causes it?

POTS is an autonomic nervous system disorder where standing triggers a heart rate increase of 30+ bpm within 10 minutes. Causes include post-viral autonomic dysfunction (especially post-COVID), autoimmune factors, deconditioning, and nervous system dysregulation. It affects an estimated 1-3 million Americans, with cases surging after COVID-19.

Can POTS be cured?

POTS does not have a single cure, but many patients achieve significant symptom reduction and improved function through multimodal treatment. Some patients with post-viral POTS see gradual improvement over months to years. Behavioral and exercise-based approaches may help retrain the nervous system, while medications manage specific symptoms.

What is the first treatment a doctor typically recommends for POTS?

Most clinicians start with non-pharmacological interventions: increased salt (10-12g/day) and fluid intake (2-3L/day), compression garments, and a graded exercise program. If these measures are insufficient, medications such as low-dose propranolol, ivabradine, or midodrine may be added.

Does exercise help or hurt POTS?

Graded exercise, starting in recumbent positions, has strong evidence for reducing POTS symptoms. The Levine Protocol begins with recumbent cardio and slowly progresses to upright exercise over 3-6 months. Starting with upright exercise too quickly can worsen symptoms, so a structured, coach-supported approach is important.

Is POTS related to anxiety?

POTS is a physiological autonomic disorder, not an anxiety disorder. However, the sympathetic nervous system activation in POTS produces overlapping symptoms (racing heart, lightheadedness, fatigue), and the emotional burden of living with POTS can contribute to stress. Behavioral therapies address both the autonomic dysregulation and the psychological impact.

Can behavioral therapy really help a heart rate problem?

Emerging research supports this. A 2026 pilot trial01039-9/abstract) adapted Pain Reprocessing Therapy specifically for POTS, finding the approach feasible and acceptable. The rationale is that POTS involves centralized nervous system dysregulation, and behavioral interventions that retrain threat processing can modulate the autonomic response that drives tachycardia.

Does insurance cover POTS treatment?

Coverage varies by treatment type. Medications like propranolol and midodrine are typically covered. Behavioral programs like Lin Health is in-network with most major insurance plans. Ivabradine is FDA-approved for heart failure (not POTS specifically), so coverage for off-label use depends on the insurer. Compression garments and salt supplementation are generally out-of-pocket.

How long does it take to see improvement with POTS treatment?

Timeline depends on the treatment. Salt and compression may provide same-day relief for some patients. Medications typically take days to weeks to reach full effect. Exercise programs show improvements at three months with continued gains through six months. Behavioral nervous system retraining is an ongoing process that builds over weeks of consistent practice.

This article is for informational purposes only and is not medical advice. Consult a qualified healthcare provider before starting, stopping, or changing any treatment for POTS. The information presented here does not replace an individualized evaluation by a physician familiar with autonomic disorders.